TerryWhite Chemmart (TWC), in partnership with Sanofi, has launched an innovative education program, Thrive, to help identify patients with type 2 diabetes and help them establish a healthcare plan to better manage their condition.
The diabetes education program will be delivered as an in-clinic offering for pharmacy staff and is accredited by the Australian Pharmacy Council and ADEA.
“Our highly trained pharmacists are here to provide the most current diabetes health advice and guidance to our patients and their carers,” TWC’s Chief Pharmacist, Brenton Hart said.
“The THRIVE program presents a new opportunity through a structured and blended learning program to further improve our pharmacist’s knowledge in this complex area of practice.
“We know that through education we can help patients better manage their condition and we are building a reputation for being the pharmacy brand of choice for patients who are living with diabetes.”
Mr Hart says working with Sanofi on this education program “has been rewarding” for the TWC network “because they have brought world-class education and innovation to our dispensaries”.
“At Sanofi, we are focussed on improving the lives of people living with diabetes,” Head of Medical General Medicines at Sanofi ANZ, James Scott said.
“This partnership with TWC delivers a differentiated education program for pharmacists and we are proud to partner with TWC pharmacists from all over the country to deliver for those living with diabetes.”
For more information about TWC’s Diabetes Clinic, visit: terrywhitechemmart.com.au.
